1h Free Analyst Time
The lateral flow assay components market is poised to grow by $97.76 mn during 2023-2027, accelerating at a CAGR of 5.22% during the forecast period. The report on the lateral flow assay components market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.Speak directly to the analyst to clarify any post sales queries you may have.
The report offers an up-to-date analysis regarding the current global market scenario, the latest trends and drivers, and the overall market environment. The market is driven by rising efforts in research and development, technological advancement, and the growing usage of home-based lateral flow assay devices.
The lateral flow assay components market is segmented as below:
By Technique Outlook
- Sandwich assays
- Competitive assays
- Multiplex detection assays
By End-user
- Medical device manufacturing companies
- Medical device contract manufacturing companies
By Geographical Landscape
- North America
- Europe
- Asia
- Rest of World (ROW)
The report on the lateral flow assay components market covers the following areas:
- Lateral flow assay components market sizing
- Lateral flow assay components market forecast
- Lateral flow assay components market industry analysis
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.
The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast accurate market growth.
Table of Contents
1 Executive Summary
2 Market Landscape
3 Market Sizing
4 Historic Market Size
5 Five Forces Analysis
6 Market Segmentation by Technique
7 Market Segmentation by End-user
8 Customer Landscape
9 Geographic Landscape
10 Drivers, Challenges, and Trends
11 Vendor Landscape
12 Vendor Analysis
13 Appendix
List of Exhibits
Executive Summary
The publisher recognizes the following companies as the key players in the global lateral flow assay components market: Abbott Laboratories, Ahlstrom Munksjo, AXIVA SICHEM Pvt. Ltd., Becton Dickinson and Co., Bio Rad Laboratories Inc., Bio Techne Corp., DxDiscovery Inc., F. Hoffmann La Roche Ltd., Geno Technology Inc., Hologic Inc., Merck KGaA, Nupore Filtration System, PerkinElmer Inc., Porex Corp., QIAGEN NV, Quidel Corp., Sartorius AG, Siemens AG, Thermo Fisher Scientific Inc., and Cytodiagnostics Inc.Commenting on the report, an analyst from the research team said: `The latest trend gaining momentum in the market is growing demand for point-of-care (POC) testing.`
According to the report, one of the major drivers for this market is the rising efforts in research and development.
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to a SWOT analysis of the key vendors.
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- Abbott Laboratories
- Ahlstrom Munksjo
- AXIVA SICHEM Pvt. Ltd.
- Becton Dickinson and Co.
- Bio Rad Laboratories Inc.
- Bio Techne Corp.
- DxDiscovery Inc.
- F. Hoffmann La Roche Ltd.
- Geno Technology Inc.
- Hologic Inc.
- Merck KGaA
- Nupore Filtration System
- PerkinElmer Inc.
- Porex Corp.
- QIAGEN NV
- Quidel Corp.
- Sartorius AG
- Siemens AG
- Thermo Fisher Scientific Inc.
- Cytodiagnostics Inc.